Development and Validation of a High‐Throughput Screening Assay for the Legionella ADP‐Ribosyl Transferase SdeA Article Swipe
Halana C. Vlaming
,
Vito Pol
,
Bjorn R. van Doodewaerd
,
Angeliki Moutsiopoulou
,
Paul P. Geurink
,
Robbert Q. Kim
,
Gerbrand J. van der Heden van Noort
·
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1002/cbic.202500513
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1002/cbic.202500513
Ubiquitination of proteins is one of the most crucial post‐translational modifications in eukaryotic cells, typically involving conjugation of ubiquitin to a lysine residue in a substrate using a three‐enzyme cascade that relies on ATP as energy source. The pathogen Legionella pneumophila , in contrast, employs a totally divergent pathway to ubiquitinate cellular host proteins in an unconventional manner that is crucial for bacterial proliferation. This multistep process is orchestrated by effector proteins from the SidE family which initially use NAD + to adenosine diphosphate (ADP)‐ribosylate ubiquitin in a mono‐ADP‐ribosyltransferase (mART) domain. The subsequent step relies on SidE phosphodiesterase activity to conjugate phosphoribosyl‐Ubiquitin to serine residues in host substrates. Through these phosphoribosyl‐ubiquitinating events, Legionella is able to gain local control over the host's ubiquitin system and simultaneously evades immune responses. Hence, pursuing new inhibitors which can disrupt these crucial steps in bacterial infection are essential towards further understanding and potentially blocking Legionella infection. Here, we present the application of an ε ‐NAD + consumption‐based fluorogenic assay to identify small molecule modulators of the SdeA effector enzyme in a High‐Throughput Screening format, where over 600 compounds were screened. As a result, a potent inhibitor named cephalosporin C Zn 2+ salt was discovered showing an IC 50 of 221 nM. To investigate the inhibitory properties more deeply, various cephalosporin analogs were synthesized where variations in charge and carbon length were introduced and their inhibitory efficiencies measured and compared. Our findings suggest that the inhibition is primarily attributed to the presence of the Zn 2+ ion, rather than the cephalosporin core. We next compared the inhibitory potential of other bivalent metal ions, illustrating that the zinc ion causes the best inhibition of the Legionella effector.
Related Topics
Concepts
No concepts available.
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1002/cbic.202500513
- OA Status
- hybrid
- References
- 67
- OpenAlex ID
- https://openalex.org/W4414613311
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4414613311Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1002/cbic.202500513Digital Object Identifier
- Title
-
Development and Validation of a High‐Throughput Screening Assay for the Legionella ADP‐Ribosyl Transferase SdeAWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-09-29Full publication date if available
- Authors
-
Halana C. Vlaming, Vito Pol, Bjorn R. van Doodewaerd, Angeliki Moutsiopoulou, Paul P. Geurink, Robbert Q. Kim, Gerbrand J. van der Heden van NoortList of authors in order
- Landing page
-
https://doi.org/10.1002/cbic.202500513Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
hybridOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1002/cbic.202500513Direct OA link when available
- Cited by
-
0Total citation count in OpenAlex
- References (count)
-
67Number of works referenced by this work
Full payload
| id | https://openalex.org/W4414613311 |
|---|---|
| doi | https://doi.org/10.1002/cbic.202500513 |
| ids.doi | https://doi.org/10.1002/cbic.202500513 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/41017758 |
| ids.openalex | https://openalex.org/W4414613311 |
| fwci | 0.0 |
| mesh[0].qualifier_ui | Q000201 |
| mesh[0].descriptor_ui | D016952 |
| mesh[0].is_major_topic | True |
| mesh[0].qualifier_name | enzymology |
| mesh[0].descriptor_name | Legionella pneumophila |
| mesh[1].qualifier_ui | Q000379 |
| mesh[1].descriptor_ui | D057166 |
| mesh[1].is_major_topic | True |
| mesh[1].qualifier_name | methods |
| mesh[1].descriptor_name | High-Throughput Screening Assays |
| mesh[2].qualifier_ui | Q000378 |
| mesh[2].descriptor_ui | D001426 |
| mesh[2].is_major_topic | True |
| mesh[2].qualifier_name | metabolism |
| mesh[2].descriptor_name | Bacterial Proteins |
| mesh[3].qualifier_ui | Q000037 |
| mesh[3].descriptor_ui | D001426 |
| mesh[3].is_major_topic | True |
| mesh[3].qualifier_name | antagonists & inhibitors |
| mesh[3].descriptor_name | Bacterial Proteins |
| mesh[4].qualifier_ui | Q000378 |
| mesh[4].descriptor_ui | D036002 |
| mesh[4].is_major_topic | True |
| mesh[4].qualifier_name | metabolism |
| mesh[4].descriptor_name | ADP Ribose Transferases |
| mesh[5].qualifier_ui | Q000037 |
| mesh[5].descriptor_ui | D036002 |
| mesh[5].is_major_topic | True |
| mesh[5].qualifier_name | antagonists & inhibitors |
| mesh[5].descriptor_name | ADP Ribose Transferases |
| mesh[6].qualifier_ui | Q000378 |
| mesh[6].descriptor_ui | D009243 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | metabolism |
| mesh[6].descriptor_name | NAD |
| mesh[7].qualifier_ui | |
| mesh[7].descriptor_ui | D008565 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | |
| mesh[7].descriptor_name | Membrane Proteins |
| mesh[8].qualifier_ui | Q000201 |
| mesh[8].descriptor_ui | D016952 |
| mesh[8].is_major_topic | True |
| mesh[8].qualifier_name | enzymology |
| mesh[8].descriptor_name | Legionella pneumophila |
| mesh[9].qualifier_ui | Q000379 |
| mesh[9].descriptor_ui | D057166 |
| mesh[9].is_major_topic | True |
| mesh[9].qualifier_name | methods |
| mesh[9].descriptor_name | High-Throughput Screening Assays |
| mesh[10].qualifier_ui | Q000378 |
| mesh[10].descriptor_ui | D001426 |
| mesh[10].is_major_topic | True |
| mesh[10].qualifier_name | metabolism |
| mesh[10].descriptor_name | Bacterial Proteins |
| mesh[11].qualifier_ui | Q000037 |
| mesh[11].descriptor_ui | D001426 |
| mesh[11].is_major_topic | True |
| mesh[11].qualifier_name | antagonists & inhibitors |
| mesh[11].descriptor_name | Bacterial Proteins |
| mesh[12].qualifier_ui | Q000378 |
| mesh[12].descriptor_ui | D036002 |
| mesh[12].is_major_topic | True |
| mesh[12].qualifier_name | metabolism |
| mesh[12].descriptor_name | ADP Ribose Transferases |
| mesh[13].qualifier_ui | Q000037 |
| mesh[13].descriptor_ui | D036002 |
| mesh[13].is_major_topic | True |
| mesh[13].qualifier_name | antagonists & inhibitors |
| mesh[13].descriptor_name | ADP Ribose Transferases |
| mesh[14].qualifier_ui | Q000378 |
| mesh[14].descriptor_ui | D009243 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | metabolism |
| mesh[14].descriptor_name | NAD |
| mesh[15].qualifier_ui | |
| mesh[15].descriptor_ui | D008565 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | |
| mesh[15].descriptor_name | Membrane Proteins |
| type | article |
| title | Development and Validation of a High‐Throughput Screening Assay for the Legionella ADP‐Ribosyl Transferase SdeA |
| biblio.issue | 21 |
| biblio.volume | 26 |
| biblio.last_page | e202500513 |
| biblio.first_page | e202500513 |
| topics[0].id | https://openalex.org/T11916 |
| topics[0].field.id | https://openalex.org/fields/13 |
| topics[0].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[0].score | 0.9911999702453613 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/1310 |
| topics[0].subfield.display_name | Endocrinology |
| topics[0].display_name | Legionella and Acanthamoeba research |
| topics[1].id | https://openalex.org/T13415 |
| topics[1].field.id | https://openalex.org/fields/13 |
| topics[1].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[1].score | 0.9872000217437744 |
| topics[1].domain.id | https://openalex.org/domains/1 |
| topics[1].domain.display_name | Life Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/1314 |
| topics[1].subfield.display_name | Physiology |
| topics[1].display_name | Calcium signaling and nucleotide metabolism |
| topics[2].id | https://openalex.org/T10981 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9814000129699707 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2713 |
| topics[2].subfield.display_name | Epidemiology |
| topics[2].display_name | Cytomegalovirus and herpesvirus research |
| is_xpac | False |
| apc_list.value | 4020 |
| apc_list.currency | USD |
| apc_list.value_usd | 4020 |
| apc_paid.value | 4020 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 4020 |
| language | en |
| locations[0].id | doi:10.1002/cbic.202500513 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S154285657 |
| locations[0].source.issn | 1439-4227, 1439-7633 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 1439-4227 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | ChemBioChem |
| locations[0].source.host_organization | https://openalex.org/P4310320595 |
| locations[0].source.host_organization_name | Wiley |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320595 |
| locations[0].source.host_organization_lineage_names | Wiley |
| locations[0].license | cc-by |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | ChemBioChem |
| locations[0].landing_page_url | https://doi.org/10.1002/cbic.202500513 |
| locations[1].id | pmid:41017758 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Chembiochem : a European journal of chemical biology |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/41017758 |
| locations[2].id | pmh:oai:europepmc.org:11405827 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S4306400806 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | Europe PMC (PubMed Central) |
| locations[2].source.host_organization | https://openalex.org/I1303153112 |
| locations[2].source.host_organization_name | European Bioinformatics Institute |
| locations[2].source.host_organization_lineage | https://openalex.org/I1303153112 |
| locations[2].license | other-oa |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | https://openalex.org/licenses/other-oa |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/12596928 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5097109195 |
| authorships[0].author.orcid | https://orcid.org/0000-0003-0971-159X |
| authorships[0].author.display_name | Halana C. Vlaming |
| authorships[0].countries | NL |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I2800006345 |
| authorships[0].affiliations[0].raw_affiliation_string | Leiden University Medical Centre Dept. Cell and Chemical Biology Leiden 2333 ZC The Netherlands |
| authorships[0].institutions[0].id | https://openalex.org/I2800006345 |
| authorships[0].institutions[0].ror | https://ror.org/05xvt9f17 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I2800006345 |
| authorships[0].institutions[0].country_code | NL |
| authorships[0].institutions[0].display_name | Leiden University Medical Center |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Halana C. Vlaming |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Leiden University Medical Centre Dept. Cell and Chemical Biology Leiden 2333 ZC The Netherlands |
| authorships[1].author.id | https://openalex.org/A5092453474 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Vito Pol |
| authorships[1].countries | NL |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I2800006345 |
| authorships[1].affiliations[0].raw_affiliation_string | Leiden University Medical Centre Dept. Cell and Chemical Biology Leiden 2333 ZC The Netherlands |
| authorships[1].institutions[0].id | https://openalex.org/I2800006345 |
| authorships[1].institutions[0].ror | https://ror.org/05xvt9f17 |
| authorships[1].institutions[0].type | healthcare |
| authorships[1].institutions[0].lineage | https://openalex.org/I2800006345 |
| authorships[1].institutions[0].country_code | NL |
| authorships[1].institutions[0].display_name | Leiden University Medical Center |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Vito Pol |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Leiden University Medical Centre Dept. Cell and Chemical Biology Leiden 2333 ZC The Netherlands |
| authorships[2].author.id | https://openalex.org/A5058535771 |
| authorships[2].author.orcid | https://orcid.org/0000-0001-9528-5587 |
| authorships[2].author.display_name | Bjorn R. van Doodewaerd |
| authorships[2].countries | NL |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I2800006345 |
| authorships[2].affiliations[0].raw_affiliation_string | Leiden University Medical Centre Dept. Cell and Chemical Biology Leiden 2333 ZC The Netherlands |
| authorships[2].institutions[0].id | https://openalex.org/I2800006345 |
| authorships[2].institutions[0].ror | https://ror.org/05xvt9f17 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I2800006345 |
| authorships[2].institutions[0].country_code | NL |
| authorships[2].institutions[0].display_name | Leiden University Medical Center |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Bjorn R. van Doodewaerd |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Leiden University Medical Centre Dept. Cell and Chemical Biology Leiden 2333 ZC The Netherlands |
| authorships[3].author.id | https://openalex.org/A5111080539 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Angeliki Moutsiopoulou |
| authorships[3].countries | NL |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I2800006345 |
| authorships[3].affiliations[0].raw_affiliation_string | Leiden University Medical Centre Dept. Cell and Chemical Biology Leiden 2333 ZC The Netherlands |
| authorships[3].institutions[0].id | https://openalex.org/I2800006345 |
| authorships[3].institutions[0].ror | https://ror.org/05xvt9f17 |
| authorships[3].institutions[0].type | healthcare |
| authorships[3].institutions[0].lineage | https://openalex.org/I2800006345 |
| authorships[3].institutions[0].country_code | NL |
| authorships[3].institutions[0].display_name | Leiden University Medical Center |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Angeliki Moutsiopoulou |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Leiden University Medical Centre Dept. Cell and Chemical Biology Leiden 2333 ZC The Netherlands |
| authorships[4].author.id | https://openalex.org/A5050982618 |
| authorships[4].author.orcid | https://orcid.org/0000-0003-1849-1111 |
| authorships[4].author.display_name | Paul P. Geurink |
| authorships[4].countries | NL |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I2800006345 |
| authorships[4].affiliations[0].raw_affiliation_string | Leiden University Medical Centre Dept. Cell and Chemical Biology Leiden 2333 ZC The Netherlands |
| authorships[4].institutions[0].id | https://openalex.org/I2800006345 |
| authorships[4].institutions[0].ror | https://ror.org/05xvt9f17 |
| authorships[4].institutions[0].type | healthcare |
| authorships[4].institutions[0].lineage | https://openalex.org/I2800006345 |
| authorships[4].institutions[0].country_code | NL |
| authorships[4].institutions[0].display_name | Leiden University Medical Center |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Paul P. Geurink |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Leiden University Medical Centre Dept. Cell and Chemical Biology Leiden 2333 ZC The Netherlands |
| authorships[5].author.id | https://openalex.org/A5083023579 |
| authorships[5].author.orcid | https://orcid.org/0000-0003-1834-8673 |
| authorships[5].author.display_name | Robbert Q. Kim |
| authorships[5].countries | NL |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I2800006345 |
| authorships[5].affiliations[0].raw_affiliation_string | Leiden University Medical Centre Dept. Cell and Chemical Biology Leiden 2333 ZC The Netherlands |
| authorships[5].institutions[0].id | https://openalex.org/I2800006345 |
| authorships[5].institutions[0].ror | https://ror.org/05xvt9f17 |
| authorships[5].institutions[0].type | healthcare |
| authorships[5].institutions[0].lineage | https://openalex.org/I2800006345 |
| authorships[5].institutions[0].country_code | NL |
| authorships[5].institutions[0].display_name | Leiden University Medical Center |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Robbert Q. Kim |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Leiden University Medical Centre Dept. Cell and Chemical Biology Leiden 2333 ZC The Netherlands |
| authorships[6].author.id | https://openalex.org/A5080047287 |
| authorships[6].author.orcid | https://orcid.org/0000-0001-5955-6431 |
| authorships[6].author.display_name | Gerbrand J. van der Heden van Noort |
| authorships[6].countries | NL |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I2800006345 |
| authorships[6].affiliations[0].raw_affiliation_string | Leiden University Medical Centre Dept. Cell and Chemical Biology Leiden 2333 ZC The Netherlands |
| authorships[6].institutions[0].id | https://openalex.org/I2800006345 |
| authorships[6].institutions[0].ror | https://ror.org/05xvt9f17 |
| authorships[6].institutions[0].type | healthcare |
| authorships[6].institutions[0].lineage | https://openalex.org/I2800006345 |
| authorships[6].institutions[0].country_code | NL |
| authorships[6].institutions[0].display_name | Leiden University Medical Center |
| authorships[6].author_position | last |
| authorships[6].raw_author_name | Gerbrand J. van der Heden van Noort |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Leiden University Medical Centre Dept. Cell and Chemical Biology Leiden 2333 ZC The Netherlands |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1002/cbic.202500513 |
| open_access.oa_status | hybrid |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Development and Validation of a High‐Throughput Screening Assay for the Legionella ADP‐Ribosyl Transferase SdeA |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-10T23:14:41.190248 |
| primary_topic.id | https://openalex.org/T11916 |
| primary_topic.field.id | https://openalex.org/fields/13 |
| primary_topic.field.display_name | Biochemistry, Genetics and Molecular Biology |
| primary_topic.score | 0.9911999702453613 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/1310 |
| primary_topic.subfield.display_name | Endocrinology |
| primary_topic.display_name | Legionella and Acanthamoeba research |
| cited_by_count | 0 |
| locations_count | 3 |
| best_oa_location.id | doi:10.1002/cbic.202500513 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S154285657 |
| best_oa_location.source.issn | 1439-4227, 1439-7633 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 1439-4227 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | ChemBioChem |
| best_oa_location.source.host_organization | https://openalex.org/P4310320595 |
| best_oa_location.source.host_organization_name | Wiley |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320595 |
| best_oa_location.source.host_organization_lineage_names | Wiley |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | ChemBioChem |
| best_oa_location.landing_page_url | https://doi.org/10.1002/cbic.202500513 |
| primary_location.id | doi:10.1002/cbic.202500513 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S154285657 |
| primary_location.source.issn | 1439-4227, 1439-7633 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 1439-4227 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | ChemBioChem |
| primary_location.source.host_organization | https://openalex.org/P4310320595 |
| primary_location.source.host_organization_name | Wiley |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320595 |
| primary_location.source.host_organization_lineage_names | Wiley |
| primary_location.license | cc-by |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | ChemBioChem |
| primary_location.landing_page_url | https://doi.org/10.1002/cbic.202500513 |
| publication_date | 2025-09-29 |
| publication_year | 2025 |
| referenced_works | https://openalex.org/W2079056345, https://openalex.org/W3152110994, https://openalex.org/W1995286508, https://openalex.org/W2900206619, https://openalex.org/W2941293471, https://openalex.org/W2615829409, https://openalex.org/W2356498392, https://openalex.org/W2789041139, https://openalex.org/W2604136844, https://openalex.org/W1982285205, https://openalex.org/W2020639312, https://openalex.org/W1988821044, https://openalex.org/W2944132034, https://openalex.org/W2036513248, https://openalex.org/W2058058143, https://openalex.org/W4390323607, https://openalex.org/W4388524105, https://openalex.org/W4220759048, https://openalex.org/W3121192774, https://openalex.org/W2982322669, https://openalex.org/W2150511318, https://openalex.org/W2735584432, https://openalex.org/W2318667448, https://openalex.org/W2089223791, https://openalex.org/W2104276267, https://openalex.org/W1967841171, https://openalex.org/W2559315320, https://openalex.org/W2803828311, https://openalex.org/W4402556020, https://openalex.org/W2983004433, https://openalex.org/W3183628817, https://openalex.org/W2085753387, https://openalex.org/W2566369865, https://openalex.org/W4405430497, https://openalex.org/W4398201180, https://openalex.org/W2072978058, https://openalex.org/W3211065192, https://openalex.org/W4392954885, https://openalex.org/W1807047686, https://openalex.org/W2963986130, https://openalex.org/W2945860513, https://openalex.org/W3024723965, https://openalex.org/W3012782066, https://openalex.org/W2138392605, https://openalex.org/W4249834124, https://openalex.org/W2020539068, https://openalex.org/W2019949449, https://openalex.org/W4233662970, https://openalex.org/W1991001144, https://openalex.org/W2626438458, https://openalex.org/W1757990252, https://openalex.org/W2043509228, https://openalex.org/W2027607694, https://openalex.org/W2105999876, https://openalex.org/W2049457768, https://openalex.org/W2030006453, https://openalex.org/W2105199391, https://openalex.org/W2116150569, https://openalex.org/W2061629679, https://openalex.org/W2123184604, https://openalex.org/W1967452520, https://openalex.org/W2123263940, https://openalex.org/W2057199226, https://openalex.org/W2148386309, https://openalex.org/W2081318066, https://openalex.org/W3138203650, https://openalex.org/W4220813692 |
| referenced_works_count | 67 |
| abstract_inverted_index.+ | 80, 161 |
| abstract_inverted_index., | 41 |
| abstract_inverted_index.C | 194 |
| abstract_inverted_index.a | 20, 24, 27, 45, 87, 176, 187, 189 |
| abstract_inverted_index.2+ | 196, 250 |
| abstract_inverted_index.50 | 203 |
| abstract_inverted_index.As | 186 |
| abstract_inverted_index.IC | 202 |
| abstract_inverted_index.To | 207 |
| abstract_inverted_index.We | 257 |
| abstract_inverted_index.Zn | 195, 249 |
| abstract_inverted_index.an | 55, 158, 201 |
| abstract_inverted_index.as | 34 |
| abstract_inverted_index.by | 69 |
| abstract_inverted_index.in | 11, 23, 42, 54, 86, 105, 139, 175, 221 |
| abstract_inverted_index.is | 3, 59, 67, 113, 241 |
| abstract_inverted_index.of | 1, 5, 17, 157, 170, 204, 247, 263, 277 |
| abstract_inverted_index.on | 32, 95 |
| abstract_inverted_index.to | 19, 49, 81, 99, 102, 115, 165, 244 |
| abstract_inverted_index.we | 153 |
| abstract_inverted_index.ε | 159 |
| abstract_inverted_index.221 | 205 |
| abstract_inverted_index.600 | 182 |
| abstract_inverted_index.ATP | 33 |
| abstract_inverted_index.NAD | 79 |
| abstract_inverted_index.Our | 235 |
| abstract_inverted_index.The | 37, 91 |
| abstract_inverted_index.and | 124, 147, 223, 228, 233 |
| abstract_inverted_index.are | 142 |
| abstract_inverted_index.can | 134 |
| abstract_inverted_index.for | 61 |
| abstract_inverted_index.ion | 272 |
| abstract_inverted_index.nM. | 206 |
| abstract_inverted_index.new | 131 |
| abstract_inverted_index.one | 4 |
| abstract_inverted_index.the | 6, 73, 120, 155, 171, 209, 239, 245, 248, 254, 260, 270, 274, 278 |
| abstract_inverted_index.use | 78 |
| abstract_inverted_index.was | 198 |
| abstract_inverted_index.SdeA | 172 |
| abstract_inverted_index.SidE | 74, 96 |
| abstract_inverted_index.This | 64 |
| abstract_inverted_index.able | 114 |
| abstract_inverted_index.best | 275 |
| abstract_inverted_index.from | 72 |
| abstract_inverted_index.gain | 116 |
| abstract_inverted_index.host | 52, 106 |
| abstract_inverted_index.ion, | 251 |
| abstract_inverted_index.more | 212 |
| abstract_inverted_index.most | 7 |
| abstract_inverted_index.next | 258 |
| abstract_inverted_index.over | 119, 181 |
| abstract_inverted_index.salt | 197 |
| abstract_inverted_index.step | 93 |
| abstract_inverted_index.than | 253 |
| abstract_inverted_index.that | 30, 58, 238, 269 |
| abstract_inverted_index.were | 184, 217, 226 |
| abstract_inverted_index.zinc | 271 |
| abstract_inverted_index.Here, | 152 |
| abstract_inverted_index.assay | 164 |
| abstract_inverted_index.core. | 256 |
| abstract_inverted_index.ions, | 267 |
| abstract_inverted_index.local | 117 |
| abstract_inverted_index.metal | 266 |
| abstract_inverted_index.named | 192 |
| abstract_inverted_index.other | 264 |
| abstract_inverted_index.small | 167 |
| abstract_inverted_index.steps | 138 |
| abstract_inverted_index.their | 229 |
| abstract_inverted_index.these | 109, 136 |
| abstract_inverted_index.using | 26 |
| abstract_inverted_index.where | 180, 219 |
| abstract_inverted_index.which | 76, 133 |
| abstract_inverted_index.(mART) | 89 |
| abstract_inverted_index.Hence, | 129 |
| abstract_inverted_index.carbon | 224 |
| abstract_inverted_index.causes | 273 |
| abstract_inverted_index.cells, | 13 |
| abstract_inverted_index.charge | 222 |
| abstract_inverted_index.energy | 35 |
| abstract_inverted_index.enzyme | 174 |
| abstract_inverted_index.evades | 126 |
| abstract_inverted_index.family | 75 |
| abstract_inverted_index.host's | 121 |
| abstract_inverted_index.immune | 127 |
| abstract_inverted_index.length | 225 |
| abstract_inverted_index.lysine | 21 |
| abstract_inverted_index.manner | 57 |
| abstract_inverted_index.potent | 190 |
| abstract_inverted_index.rather | 252 |
| abstract_inverted_index.relies | 31, 94 |
| abstract_inverted_index.serine | 103 |
| abstract_inverted_index.system | 123 |
| abstract_inverted_index.‐NAD | 160 |
| abstract_inverted_index.Through | 108 |
| abstract_inverted_index.analogs | 216 |
| abstract_inverted_index.cascade | 29 |
| abstract_inverted_index.control | 118 |
| abstract_inverted_index.crucial | 8, 60, 137 |
| abstract_inverted_index.deeply, | 213 |
| abstract_inverted_index.disrupt | 135 |
| abstract_inverted_index.domain. | 90 |
| abstract_inverted_index.employs | 44 |
| abstract_inverted_index.events, | 111 |
| abstract_inverted_index.format, | 179 |
| abstract_inverted_index.further | 145 |
| abstract_inverted_index.pathway | 48 |
| abstract_inverted_index.present | 154 |
| abstract_inverted_index.process | 66 |
| abstract_inverted_index.residue | 22 |
| abstract_inverted_index.result, | 188 |
| abstract_inverted_index.showing | 200 |
| abstract_inverted_index.source. | 36 |
| abstract_inverted_index.suggest | 237 |
| abstract_inverted_index.totally | 46 |
| abstract_inverted_index.towards | 144 |
| abstract_inverted_index.various | 214 |
| abstract_inverted_index.activity | 98 |
| abstract_inverted_index.bivalent | 265 |
| abstract_inverted_index.blocking | 149 |
| abstract_inverted_index.cellular | 51 |
| abstract_inverted_index.compared | 259 |
| abstract_inverted_index.effector | 70, 173 |
| abstract_inverted_index.findings | 236 |
| abstract_inverted_index.identify | 166 |
| abstract_inverted_index.measured | 232 |
| abstract_inverted_index.molecule | 168 |
| abstract_inverted_index.pathogen | 38 |
| abstract_inverted_index.presence | 246 |
| abstract_inverted_index.proteins | 2, 53, 71 |
| abstract_inverted_index.pursuing | 130 |
| abstract_inverted_index.residues | 104 |
| abstract_inverted_index.Screening | 178 |
| abstract_inverted_index.adenosine | 82 |
| abstract_inverted_index.bacterial | 62, 140 |
| abstract_inverted_index.compared. | 234 |
| abstract_inverted_index.compounds | 183 |
| abstract_inverted_index.conjugate | 100 |
| abstract_inverted_index.contrast, | 43 |
| abstract_inverted_index.divergent | 47 |
| abstract_inverted_index.effector. | 280 |
| abstract_inverted_index.essential | 143 |
| abstract_inverted_index.infection | 141 |
| abstract_inverted_index.inhibitor | 191 |
| abstract_inverted_index.initially | 77 |
| abstract_inverted_index.involving | 15 |
| abstract_inverted_index.multistep | 65 |
| abstract_inverted_index.potential | 262 |
| abstract_inverted_index.primarily | 242 |
| abstract_inverted_index.screened. | 185 |
| abstract_inverted_index.substrate | 25 |
| abstract_inverted_index.typically | 14 |
| abstract_inverted_index.ubiquitin | 18, 85, 122 |
| abstract_inverted_index.Legionella | 39, 112, 150, 279 |
| abstract_inverted_index.attributed | 243 |
| abstract_inverted_index.discovered | 199 |
| abstract_inverted_index.eukaryotic | 12 |
| abstract_inverted_index.infection. | 151 |
| abstract_inverted_index.inhibition | 240, 276 |
| abstract_inverted_index.inhibitors | 132 |
| abstract_inverted_index.inhibitory | 210, 230, 261 |
| abstract_inverted_index.introduced | 227 |
| abstract_inverted_index.modulators | 169 |
| abstract_inverted_index.properties | 211 |
| abstract_inverted_index.responses. | 128 |
| abstract_inverted_index.subsequent | 92 |
| abstract_inverted_index.variations | 220 |
| abstract_inverted_index.application | 156 |
| abstract_inverted_index.conjugation | 16 |
| abstract_inverted_index.diphosphate | 83 |
| abstract_inverted_index.fluorogenic | 163 |
| abstract_inverted_index.investigate | 208 |
| abstract_inverted_index.pneumophila | 40 |
| abstract_inverted_index.potentially | 148 |
| abstract_inverted_index.substrates. | 107 |
| abstract_inverted_index.synthesized | 218 |
| abstract_inverted_index.efficiencies | 231 |
| abstract_inverted_index.illustrating | 268 |
| abstract_inverted_index.orchestrated | 68 |
| abstract_inverted_index.ubiquitinate | 50 |
| abstract_inverted_index.cephalosporin | 193, 215, 255 |
| abstract_inverted_index.modifications | 10 |
| abstract_inverted_index.understanding | 146 |
| abstract_inverted_index.Ubiquitination | 0 |
| abstract_inverted_index.proliferation. | 63 |
| abstract_inverted_index.simultaneously | 125 |
| abstract_inverted_index.three‐enzyme | 28 |
| abstract_inverted_index.unconventional | 56 |
| abstract_inverted_index.High‐Throughput | 177 |
| abstract_inverted_index.phosphodiesterase | 97 |
| abstract_inverted_index.(ADP)‐ribosylate | 84 |
| abstract_inverted_index.consumption‐based | 162 |
| abstract_inverted_index.post‐translational | 9 |
| abstract_inverted_index.phosphoribosyl‐Ubiquitin | 101 |
| abstract_inverted_index.mono‐ADP‐ribosyltransferase | 88 |
| abstract_inverted_index.phosphoribosyl‐ubiquitinating | 110 |
| cited_by_percentile_year | |
| countries_distinct_count | 1 |
| institutions_distinct_count | 7 |
| citation_normalized_percentile.value | 0.37550565 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |